News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Meet Dr. Stefania Morganti – Dana-Farber’s Breast Oncology Center
Stefania Morganti
Dec 11, 2024, 09:20

Meet Dr. Stefania Morganti – Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X:

“Meet Dr. Stefania Morganti, an Advanced Fellow at the Breast Oncology Center Dana-Farber.

Originally from Italy, Dr. Morganti earned her MD at the University of Pavia and specialized in Medical Oncology at the University of Milan and the European Institute of Oncology.

Her work is focused on translational research aimed at developing innovative, patient-centered approaches to advance Breast Cancer treatment.”

Meet Dr. Stefania Morganti - Dana-Farber’s Breast Oncology Center

Breast Cancer cancer Dana-Farber Dana-Farber’s Breast Oncology Center European Institute of Oncology fight against cancer Global fight against cancer Italy medical oncology OncoDaily Oncology Stefania Morganti University of Pavia
Special Coverage
Blog
Jan 9, 2025, 17:18
Fumiko Ladd Chino: 2025  ASCO JCO Journals Editorial Fellow Application is OPEN
Insight
Jan 9, 2025, 17:18
Jessica MacIntyre: Excited for this year’s 50th Annual Oncology Nursing Society Congress
Blog
Jan 9, 2025, 17:04
Mehdi Hamadani: Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide
Blog
Jan 9, 2025, 16:48
Design of a Fc-engineered tetravalent bispecific antibody targeting PD-1 and VEGF with cooperative biological effects
Blog
Jan 9, 2025, 16:41
Elisabetta Munzone: Harmonizing EHRs in Italy for Better Healthcare Outcomes and Cost Reduction
Blog
Jan 9, 2025, 16:38
Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
Blog
Jan 9, 2025, 16:35
Ahmed Kotb: Ph-like ALL Signaling Pathways and Targets
Blog
Jan 9, 2025, 16:32
Priorities of ESTRO for engagement within the EURAMED framework
Blog
Jan 9, 2025, 16:29
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Blog
Jan 9, 2025, 16:22
Isabel Preeshagul: Survey on addressing barriers to clinical trial accrual in patients with lung cancer
Blog
Jan 9, 2025, 16:20
Saddened to learn of the unexpected passing of Prof. Petra Feyer - MASCC
Blog
Jan 9, 2025, 16:07
Eric Racine: The Patient Advocacy Voices Podcast is Back for 2025